SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Contract with Customer, Liability
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Contract with Customer, Liability of -$8.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-06-30 was -$8.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2026-03-31 was -$29.00K, a 109.03% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was -$449.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was $52.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2026 was -$452.00K, a 349.72% decline from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2025 was $181.00K, a 49.01% decline from fiscal 2024.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2024 was $355.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in contract with customer, liability for fiscal 2023 was -$1.30M, a 244.00% decline from fiscal 2022.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 3 month as first filed | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$8.00K 10-Q · filed 2026-08-06 | -$37.00K derived: sum of 2 quarters · filed 2026-08-06 | -$486.00K derived: sum of 3 quarters · filed 2026-08-06 | -$434.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | -$478.00K derived: sum of 2 quarters · filed 2026-06-16 | -$426.00K derived: sum of 3 quarters · filed 2026-06-16 | -$452.00K 10-K · filed 2026-06-16 | |
| 2025-12-31 | -$449.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | -$397.00K derived: sum of 2 quarters · filed 2026-02-10 | -$423.00K 10-Q · filed 2026-02-10 | -$102.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-09-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $26.00K 10-Q · filed 2025-11-04 | $347.00K derived: sum of 3 quarters · filed 2026-08-06 | $335.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$26.00K 10-Q · filed 2026-08-06 | $26.00K 10-Q · filed 2025-08-07 | $295.00K derived: sum of 2 quarters · filed 2026-08-06 | $283.00K derived: sum of 3 quarters · filed 2026-08-06 | $200.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $309.00K derived: sum of 2 quarters · filed 2026-06-16 | $226.00K derived: sum of 3 quarters · filed 2026-06-16 | $181.00K 10-K · filed 2026-06-16 | |
| 2024-12-31 | -$12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | -$95.00K derived: sum of 2 quarters · filed 2026-02-10 | -$140.00K 10-Q · filed 2026-02-10 | $182.00K derived: sum of 4 quarters · filed 2026-02-10 | |
| 2024-09-30 | -$83.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | -$128.00K 10-Q · filed 2025-11-04 | $194.00K derived: sum of 3 quarters · filed 2025-11-04 | $258.00K derived: sum of 4 quarters · filed 2025-11-04 | |
| 2024-06-30 | -$45.00K 10-Q · filed 2025-08-07 | $277.00K derived: sum of 2 quarters · filed 2025-08-07 | $341.00K derived: sum of 3 quarters · filed 2025-08-07 | $321.00K derived: sum of 4 quarters · filed 2025-08-07 | |
| 2024-03-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | $386.00K derived: sum of 2 quarters · filed 2025-06-17 | $366.00K derived: sum of 3 quarters · filed 2025-06-17 | $355.00K 10-K · filed 2025-06-17 | |
| 2023-12-31 | $64.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | $44.00K derived: sum of 2 quarters · filed 2025-02-05 | $33.00K 10-Q · filed 2025-02-05 | -$59.00K derived: sum of 4 quarters · filed 2025-02-05 | |
| 2023-09-30 | -$20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | -$31.00K 10-Q · filed 2024-11-07 | -$123.00K derived: sum of 3 quarters · filed 2024-11-07 | -$178.00K derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | -$11.00K 10-Q · filed 2024-08-08 | -$103.00K derived: sum of 2 quarters · filed 2024-08-08 | -$158.00K derived: sum of 3 quarters · filed 2024-08-08 | -$170.00K derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$92.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | -$147.00K derived: sum of 2 quarters · filed 2024-06-17 | -$159.00K derived: sum of 3 quarters · filed 2024-06-17 | -$1.30M 10-K · filed 2024-06-17 | |
| 2022-12-31 | -$55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$67.00K derived: sum of 2 quarters · filed 2024-02-08 | -$1.20M 10-Q · filed 2024-02-08 | -$247.00K derived: sum of 4 quarters · filed 2024-02-08 | |
| 2022-09-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$1.15M 10-Q · filed 2023-11-13 | -$192.00K derived: sum of 3 quarters · filed 2023-11-13 | -$55.00K derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | -$1.14M 10-Q · filed 2023-08-10 | -$180.00K derived: sum of 2 quarters · filed 2023-08-10 | -$43.00K derived: sum of 3 quarters · filed 2023-08-10 | -$140.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $957.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | $1.09M derived: sum of 2 quarters · filed 2023-06-21 | $997.00K derived: sum of 3 quarters · filed 2023-06-21 | $900.00K 10-K · filed 2023-06-21 | |
| 2021-12-31 | $137.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | $40.00K derived: sum of 2 quarters · filed 2023-02-14 | -$57.00K 10-Q · filed 2023-02-14 | $47.00K derived: sum of 4 quarters · filed 2023-02-14 | |
| 2021-09-30 | -$97.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | -$194.00K 10-Q · filed 2022-11-14 | -$90.00K derived: sum of 3 quarters · filed 2022-11-14 | -$107.00K derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | -$97.00K 10-Q · filed 2022-08-11 | $7.00K derived: sum of 2 quarters · filed 2022-08-11 | -$10.00K derived: sum of 3 quarters · filed 2022-08-11 | -$13.00K derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $104.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | $87.00K derived: sum of 2 quarters · filed 2022-07-13 | $84.00K derived: sum of 3 quarters · filed 2022-07-13 | -$15.00K 10-K · filed 2022-07-13 | |
| 2020-12-31 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | -$20.00K derived: sum of 2 quarters · filed 2022-02-11 | -$119.00K 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | -$102.00K 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | -$99.00K 10-Q · filed 2021-08-16 | ||||
| 2020-03-31 | -$97.00K 10-K · filed 2021-07-14 | ||||
| 2019-03-31 | -$152.00K 10-K · filed 2020-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |